1.Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus:implications for virus origins and receptor binding. Lancet. 2020;395(10224):565-574.doi:10.1016/S0140-6736(20)30251-8
2.Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus ofprobable bat origin. Nature. 2020;579(7798):270-273. doi:10.1038/s41586-020-2012-7
3.Goel S, Jain T, Hooda A, et al. Clinical Characteristics and In-Hospital Mortality for COVID-19Across The Globe [published online ahead of print, 2020 Jul 18]. Cardiol Ther. 2020;1-7. doi:10.1007/s40119-020-00189-0
4.van Lunzen J, Altfeld M. Sex differences in infectious diseases-common but neglected. J InfectDis. 2014;209 Suppl 3:S79-S80. doi:10.1093/infdis/jiu159
5.Kovats S. Estrogen receptors regulate innate immune cells and signaling pathways. Cell Immunol.2015;294(2):63-69. doi:10.1016/j.cellimm.2015.01.018
6.Jin JM, Bai P, He W, et al. Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Front Public Health. 2020;8:152. Published 2020 Apr 29. doi:10.3389/fpubh.2020.00152
7.Sharma G, Volgman AS, Michos ED. Sex Differences in Mortality from COVID-19 Pandemic: Are Men Vulnerable and Women Protected? [published online ahead of print, 2020 May 4]. JACC Case Rep. 2020;2(9):1407-1410. doi:10.1016/j.jaccas.2020.04.027
8.Zhang L, Wang Z, Wang X, et al. Prevalence of overweight and obesity in China: Results from across-sectional study of 441 thousand adults, 2012-2015. Obes Res Clin Pract. 2020;14(2):119-126. doi:10.1016/j.orcp.2020.02.005
9.Zhang X, Zhang M, Zhao Z, et al. Geographic Variation in Prevalence of Adult Obesity in China:Results From the 2013-2014 National Chronic Disease and Risk Factor Surveillance. Ann Intern Med. 2020;172(4):291-293. doi:10.7326/M19-0477
10.National health commission, PRC. COVID 19 diagnosis and treatment programme (trial version 7) [EB/OL].(2020-03-03)[2020-03-04].
http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9 294a7dfe4cef80dc7f5912eb1989.shtml.
11.Karlberg J, Chong DS, Lai WY. Do men have a higher case fatality rate of severe acute respiratorysyndrome than women do?. Am J Epidemiol. 2004;159(3):229-231. doi:10.1093/aje/kwh056
12.Alghamdi IG, Hussain II, Almalki SS, Alghamdi MS, Alghamdi MM, El-Sheemy MA. The patternof Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptiveepidemiological analysis of data from the Saudi Ministry of Health. Int J Gen Med. 2014;7:417-423. Published 2014 Aug 20. doi:10.2147/IJGM.S67061
13.vom Steeg LG, Klein SL. SeXX Matters in Infectious Disease Pathogenesis. PLoS Pathog.2016;12(2):e1005374. Published 2016 Feb 18. doi:10.1371/journal.ppat.1005374
14.Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus inWuhan, China [published correction appears in Lancet. 2020 Jan 30;:]. Lancet.2020;395(10223):497-506. doi:10.1016/S0140-6736(20)30183-5
15.Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 NovelCoronavirus-Infected Pneumonia in Wuhan, China [published online ahead of print, 2020Feb 7]. JAMA. 2020;323(11):1061-1069. doi:10.1001/jama.2020.1585
16.Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. NEngl J Med. 2020;382(18):1708-1720. doi:10.1056/NEJMoa2002032
17.Mo P, Xing Y, Xiao Y, et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan,China [published online ahead of print, 2020 Mar 16]. Clin Infect Dis. 2020;ciaa270. doi:10.1093/cid/ciaa270
18.Lan J, Ge J, Yu J, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to theACE2 receptor. Nature.2020;581(7807):215-220. doi:10.1038/s41586-020-2180-5
19.Ling Ma, Wen Xie Danyang Li, et al . Effect of SARS-CoV-2 infection upon male gonadal function A single center-based study, Preprints with The Lancet .doi:https://doi.org/10.1101/2020.3.21.20037267
20.Kloc M, Ghobrial RM, Kubiak JZ. The Role of Genetic Sex and Mitochondria in Response to COVID-19 Infection [published online ahead of print, 2020 Jun 19]. Int Arch AllergyImmunol. 2020;1-6. doi:10.1159/000508560
21.Culebras E, Hernández F. ACE2 is on the X chromosome: could this explain COVID-19 genderdifferences? [published online ahead of print, 2020 Jun 24]. Eur Heart J. 2020;ehaa521.doi:10.1093/eurheartj/ehaa521
22.Stelzig KE, Canepa-Escaro F, Schiliro M, Berdnikovs S, Prakash YS, Chiarella SE. Estrogenregulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelialcells. Am J Physiol Lung Cell Mol Physiol. 2020;318(6):L1280-L1281. doi:10.1152/ajplung.00153.202023.Walter LA, McGregor AJ. Sex- and Gender-specific Observations and Implications for COVID-19. West J Emerg Med. 2020;21(3):507-509. Published 2020 Apr 10.doi:10.5811/westjem.2020.4.47536
24.Wei ZY, Qian HY, Huang J, Geng YJ. Pathogenesis and Management of Myocardial Injury in Coronavirus Disease 2019 [published online ahead of print, 2020 Jul 19]. Eur J Heart Fail.2020;10.1002/ejhf.1967. doi:10.1002/ejhf.1967
25.Zhu X, Ge Y, Wu T, et al. Co-infection with respiratory pathogens among COVID-2019cases. Virus Res. 2020;285:198005. doi:10.1016/j.virusres.2020.198005
26.Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients withCOVID-19. Lancet Haematol. 2020;7(6):e438-e440. doi:10.1016/S2352-3026(20)30145-9
27.Cai Q, Chen F, Wang T, et al. Obesity and COVID-19 Severity in a Designated Hospital inShenzhen, China. Diabetes Care. 2020;43(7):1392-1398. doi:10.2337/dc20-0576
28.Petrakis D, Margină D, Tsarouhas K, et al. Obesity ‑ a risk factor for increased COVID‑19prevalence, severity and lethality (Review). Mol Med Rep. 2020;22(1):9-19. doi:10.3892/mmr.2020.11127
29.Bianchi VE.The Anti-Inflammatory Effects of Testosterone. J Endocr Soc. 2018;3(1):91-107.Published 2018 Oct 22. doi:10.1210/js.2018-00186
30.Spagnolo PA, Manson JE, Joffe H. Sex and Gender Differences in Health: What the COVID-19Pandemic Can Teach Us [published online ahead of print, 2020 May 8]. Ann Intern Med. 2020;M20-1941. doi:10.7326/M20-1941
31.Liu Y, Yan LM, Wan L, et al. Viral dynamics in mild and severe cases of COVID-19. Lancet InfectDis. 2020;20(6):656-657. doi:10.1016/S1473-3099(20)30232-2